Overview

A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone

Status:
Completed
Trial end date:
2012-02-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of tanezumab in combination with opioids in treating pain due to cancer that has spread to bone.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Analgesics, Opioid
Tanezumab